Actu Pharmacovigi...
Follow
Find tag "GVP"
8.7K views | +11 today
Actu Pharmacovigilance
L'actualité réglementaire de la pharmacovigilance en Europe
Your new post is loading...
Scooped by EVELYNE PIERRON
Scoop.it!

European Medicines Agency - News and Events - European Medicines Agency finalises first set of guidelines on good pharmacovigilance practices

The European Medicines Agency has published the first set of finalised modules of the guideline on good pharmacovigilance practices (GVP) today.

The finalisation of these seven modules is a key deliverable of the 2010 pharmacovigilance legislation, which will apply from Monday 2 July 2012. Each of the modules covers one major process in the safety monitoring of medicines.

These are:

Module I: Pharmacovigilance systems and their quality systems;
Module II: Pharmacovigilance systems master files;
Module V: Risk management systems;
Module VI: Management and reporting of adverse reactions to medicinal products;
Module VII: Periodic safety update reports;
Module VIII: Post-authorisation safety studies;
Module IX: Signal management.


On Wednesday 27 June 2012, the Agency will be publishing two further GVP modules for public consultation. These will be:

Module III: Pharmacovigilance inspections;
Module X: Additional monitoring.


The finalised GVP modules on post-authorisation safety studies and risk management plans refer to the guide on methodological standards in pharmacoepidemiology, which is available on the website of the European Network of Centres in Pharmacoepidemiology and Pharmacovigilance (ENCePP).


more...
No comment yet.
Scooped by EVELYNE PIERRON
Scoop.it!

Public consultation - Good Pharmacovigilance Practices

The European Medicines Agency has released the first batch of modules on good pharmacovigilance practices (GVP) for public consultation until 18 April 2012. The release of these modules is a key deliverable of the 2010 pharmacovigilance legislation, which will apply from July 2012. 

more...
No comment yet.
Curated by EVELYNE PIERRON
Médecin, veilleur de sa communauté #pharmacovigilance, passionnée de #sécurité sanitaire, de #santé publique et GEEK à mes temps perdus.